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Otomycosis, chronic or recurrent in 
nature, has been observed most frequently 
in tropical or subtropical countries (Sen-
turia 1957), but it would seem that its inci-
dence is increasing (Scott Brown); this, 
perhaps, also as a result of widespread use 
of topical antibiotic preparations, in the 
treatment of otitis externa. The fungi 
most frequently found in otomycosis are 
Aspergillus niger and Candida albicans; 
fungi thrive in moist conditions and in the 
presence of epithelial debris. 
A large majority of fungal infections 
arose during the topical use of broad spec-
trum antibiotics, the probability of fungal 
implication in an infection appearing to 
be proportional to the duration of the anti-
biotic treatment (Smyth). 
The exudate occuring in bacterial ear 
infections seems likely to provide a degree 
of humidity favourable to fungal prolIfera-
tion and it is clear that bacteria and fungi 
can coeixst in the same clinical condition. 
Antibiotic therapy then might suppress 
the bacteria primarily responsible, leaving 
the fungi free to grow. It is suggested that 
the normal secretion of the meatus may 
have an inhibiting effect on fungal proli-
feration. Senturia (1957) quotes several 
authorities who state that most of the 
saturated and unsaturated fatty acids have 
some inhibitory effect on the majority of 
fungi. 
Aspergillus niger is perhaps (M. P. 
English) the most common cause of oto-
mycosis of the intact ear. Fungi are wide-
spread outside the human body, being 
primarily saprophytic and of world wide 
distribution. They occur in the soil and on 
all sorts of decaying vegetable matter, and 
in the air of residential districts. It is 
therefore not difficult to think of possible 
sources of aural infection. 
The development of fungal external 
otitis (Gavin, Hildrick, Smith and Sokra-
ny) is associated with local itching which 
coincides with the proliferation of the or-
ganism in the external auditory canal and 
is followed by the progression of the con-
dition to produce varying degrees of pain 
and a clinical picture of mild to severe 
local inflammation associated with ~ se-
rous discharge. Untreated advanced le-
sions are sometimes accompanied by the 
overgrowth of the fungi which give the 
appearance of a cotton-like mass of mate-
rial, similar to damp or macerated blotting 
paper, lodged in the external auditory 
canal. Smyth (1961) claimed that Asper-
gillus niger infections appear to be regu-
larly accompanied by pain and are difficult 
to eradicate completely. 
Patients complain of itching and ful-
ness in the ear (Senturia 1957) and slight 
difficulty in hearing. In more severe cases 
the patient complains of intense pain in 
the ear when chewing, and of deafness 
and tinnitus. In Aspergillus niger infec-
tions the skin of the osseous meatus and 
tympanic membrane is covered with a 
velvety grey, blotting paper like mem-
brane, marked with black spots and giving 
the appearance of having been sprinkled 
with fine coal dust. The membrane which 
may be washed out of the ear canal has 
a whitish or dirty grey colour. After the 
removal of such membranes the skin of 
the osseous canal and the tympanic mem-
brane appears very red and swollen and 
in part devoid of its epidermal layer. 
From the diagnostic point of view 
(Gregson and La Touche 1961) there are 
three features which should arouse the 
suspicion of mycotic infection: 
l. Relapse after, or resistance to, 
standard treatment. 
2. The symptom of irritation. 
3. A history of local antibiotic the-
rapy. 
Treatment 
The first rule in the case of fungus 
infection of the ear canal is to remove 
thoroughly all the accumulated debris in 
the ear canal or post operative mastoid 
cavity. This is accomplished by the remo-
val of the larger central masses with a 
dull curette. In very sensitive patients the 
ear canal or mastoid cavity is syringed 
with sterile water at body temperature 
and the debris removed. 
If the treatment is limited to simple 
cleansing and to the removal of detritus 
from the canal without the use of fungi-
cides and where necessary bactericides, 
the canal or cavity may be completely 
refilled with the same sort of debris within 
a few days. 
Several prep!lrations are used in the 
treatment of otomycosis because of their 
fungicidal action. 
The ear canal may be wiped with a 
solution of 2% thymol in 70% alcohol. 
This may cause exfoliation or maceration 
of the skin, otorrhea occurs and treatment 
has to be discontinued. Full strength meta-
cresyl acetate may be used, but the pa~ient 
may be hypersensitive to this drug. 2% 
gentian violet in 70% alcohol is also used, 
but there is the objection to the use of 
dyes in and around the ear. 2% salicylic 
acid in absolute alcohol is also effective 
but in several cases it causes severe pain 
and irritation of the skin of the meatus. 
The most widely used preparation is Nys-
tatin, which is employed as a powder or 
as a cream. This is fungistatic and not 
fungicidal (M. P. English), and deteriorates 
in warm moist conditions. Some patients 
develop furunculosis while under treat-
ment with this preparation (La Touche and 
Gregson 1961). 
Thirty patients suffering from Otomy-
cosis due to Aspergillus niger were treated 
with Tinaderm, with '{ery good results. 
Tinaderm is in extensive use for the treat-
meant of fungal skin infections in other 
parts of the body, but as far as is known 
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this is the first record of its use in otomy-
cosis. 
The diagnosis of otomycosis was 
made clinically but confirmation of infec-
tion by Aspergillus niger, was obtained 
by mycological studies in ten cases. Of 
the thirty cases, two affected post ope-
rative mastoid cavities and in six cases, 
a central perforation was present. 
No pain or other symptoms were 
complained of, when Tinaderm was used, 
except in the case of the two mastoid 
cavities and when a central perforation 
was present. In these cases the patient 
complained of slight stinging. 
Debris was removed by a dull curette 
and in nervous patients by syringing with 
sterile water at body temperature. The 
meatus was then mopped dry, with cotton 
wool tipped probes and then filled with 
Tinaderm Solution. The external auditory 
canal or cavity was then packed slightly 
with ! inch selve edged ribbon gauze. 
The patient was instructed to keep the 
gauze moist by instilling on it, six drops 
three times daily for three days. At the 
end of this period, the ribbon gauze was 
removed and the drops instilled directly 
into the meatus, six drops three times daily 
for a further period of three days. The 
patient continued with the drops, six drops 
twice daily, for another six days. 
The itching and irritation in the ear 
disappeared within the first 48 hours of 
the commencement of treatment. All 
thirty cases cleared up with this treat-
ment, and when seen after a month no 
recurrence was found in any. 
In 1960, Japanese investigators syn-
thetised a new group of antifungal agents 
with local action. These substances were 
designated generically as Naphthiomates. 
"Tinaderm", Tolnaftate 1% solution in 
Polyethylene Glycol 400 is one of these 
substances. Chemically it is 0-2 Naphtyl 
m N-Dimethyl-Thiocarbanilate. 
In vitro studies of antibacterial and 
antifungal activities, show Tinaderm to be 
a potent antifungal agent, against, among 
other fungi, Aspergillus niger. It is entirely 
inert against gram-positive and gram-
negative bacteria. Tinaderm is apparently 
of no value in the treatment of cutaneous 
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lesions due to Candida albicans. Tinaderm 
was found to be ineffective by systemic 
administration. It has no local or systemic 
side effects. Tolnaftates are soluble in or-
ganic solvents but are virtually insoluble 
in water. These preparations are odour-
less, colourless and greaseless. It also does 
not stain or discolour the skin, haIr or 
clothing. The toxicity to man on topical 
application or on oral administration is 
virtually negligible. There is no primary 
irritation or acquired contact sensitivity. 
It can be used with impunity on severely 
irritated skin. All patch tests for sensitivity 
have been negative. 
Several preparations used in the treat-
ment of fungus skin infection act by virtue 
of the keratolytic effect produced by them. 
Tinaderm has proved itself to be an ex-
cellent fungicide acting as a chemical and 
not by peeling or exfoliation. 
Luedemann has tried to demonstrate 
the antifungal activity of Tolnaftate. He 
found that the drug distorted the hyphae 
and stunted the mycelial growth of ger-
minating spores of susceptible fungi. 
My thanks are due to Dr. E. Agius 
for mycological work and !o the Schering 
Corporation, U.S.A., for their generous 
supply of the necessary samples for this 
work. 
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NOTICE 
This periodical is published biannually, in June and in Decem-
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Bacteriological Laboratory, St. Luke's Hospital, by the 1st May. 
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